Start Willow vs bmiMD: Compounded Semaglutide vs Tirzepatide Plans
Start Willow vs bmiMD compares a compounded semaglutide direct-pay program with a compounded tirzepatide subscription that emphasizes lower long-term pricing. Early verdict: choose Start Willow if you want a no-insurance, no-membership route and fastest delivery; choose bmiMD if lower long-term monthly cost and free subscription shipping matter more.
Explore Start Willow plans from $249/month
What each provider sells and regulatory context
Start Willow markets a once-weekly compounded semaglutide injection described as a customized treatment option. Start Willow states these are compounded alternatives using the same active ingredients as Ozempic and tirzepatide and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. bmiMD offers compounded tirzepatide, described as a compounded GLP-1/GIP product, and also states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Price structure and billing commitments
Start Willow lists a first-month price of $249 and an ongoing rate of $299/month, with no membership fees and no insurance required. bmiMD lists tiered monthly equivalents: $179 month-to-month, $159 for three months, $149 for six months, and $139 for a 12-month plan. bmiMD notes the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
See bmiMD pricing and subscription options
Delivery speed, shipping and refill model
Start Willow promises delivery in 3 days or less from its licensed pharmacy network and advertises same day prescriptions and free 2-Day shipping in captured landing-page evidence. bmiMD offers free shipping on every subscription order and focuses on online refills and delivery, with clinician confirmation intervals and independent lab verification statements on its pages.
Clinical access and online care differences
Start Willow emphasizes a direct-pay model that bypasses insurance and prior-authorization, prescribing after an online clinician review and delivering via a licensed pharmacy network. bmiMD highlights 24/7 clinician access, online refills, and clinician confirmation every 3 to 6 months to stay within target strength tolerances. Both require a licensed clinician to determine medical appropriateness.
Distinctive differences at a glance
| Criteria | Start Willow | bmiMD |
|---|---|---|
| Active compound | Compounded semaglutide | Compounded tirzepatide (GLP-1/GIP) |
| Starting price | From $249 first month; $299/month ongoing | $179 month-to-month; as low as $139/month with 12-month plan |
| Shipping | Delivery in 3 days or less; free 2-Day shipping claimed | Free shipping on every subscription order |
| Insurance and membership | No insurance needed and no membership fees | Subscription options with prepaid commitments for lower rates |
| Clinician access | Online clinician review before prescription | 24/7 clinician access and clinician confirmation every 3 to 6 months |
Side effects and safety notices from each source
Start Willow includes patient safety information stating common side effects of semaglutide are usually mild and may include nausea, and that compounded semaglutide is not FDA-approved. bmiMD captures a regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The bmiMD source includes statements about independent verification in FDA- and DEA-registered labs for its pharmacy preparations.
User experience and best-fit guidance
Start Willow positions itself for patients frustrated by insurance pre-authorization, offering a direct-pay path with fast delivery and no membership. bmiMD positions itself for patients willing to confirm eligibility and commit to longer subscriptions for a lower long-term monthly price, with free subscription shipping and 24/7 clinician access.
Start Willow: Check availability and shipping times
Quick comparison recap
Start Willow vs bmiMD differs mainly by compound offered, price model, shipping promise, clinician access structure, and subscription commitments. Start Willow: compounded semaglutide, direct-pay, no insurance, fast 3-day delivery, $249 first month then $299 ongoing. bmiMD: compounded tirzepatide, multi-month pricing as low as $139/month with a 12-month plan, free subscription shipping, 24/7 clinician access, and prepaid commitments for lowest rates.
Compare Start Willow options now
Choose which provider if…
Choose Start Willow if you need a no-insurance, no-membership direct-pay option with a guaranteed fast delivery window and prefer compounded semaglutide prescribed after an online clinician review.
Choose bmiMD if you prioritize a lower long-term monthly equivalent and free subscription shipping and are willing to confirm eligibility and accept a multi-month commitment for the lowest rate.